Winston-Salem, North Carolina Clinical Trials

A listing of Winston-Salem, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 34 clinical trials
CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma

The purpose of this study is to determine if it is possible to give CPI-613 with the drug Bendamustine for 2 days every 28 days without causing severe side effects. In addition, this study will also test the safety of CPI-613 when given in combination with Bendamustine.

neutrophil count
ultraviolet light therapy
mycosis fungoides
metastasis
oral contraceptives
Wake Forest Baptist Comprehensive Cancer Center
 (1.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
SPRINT Peripheral Nerve Stimulation for the Treatment of Back Pain

The purpose of this study is to compare standard of care treatments for back pain to electrical stimulation. Electrical stimulation is delivering small amounts of electricity to the nerves in your low back. This study will use a device called the SPRINT Peripheral Nerve Stimulation (PNS) System. The SPRINT PNS …

peripheral nerve stimulation
chronic pain
back pain
low back pain
electrical stimulation
Center for Clinical Research
 (5.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

This pilot study is configured as a non-inferiority comparison of Performance Status 2 patients with Performance Status 0-1 patients, with the goal of demonstrating non-inferiority in terms of efficacy (progression-free survival, overall survival) and safety (rates of adverse events, quality of life) when treating Performance Status 2 patients with the …

neutrophil count
lung cancer
carboplatin/paclitaxel
metastasis
dyspnea
Wake Forest Baptist Comprehensive Cancer Center
 (3.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

This is a Phase II treatment, non-randomized, open label clinical trial to study the efficacy of the Cetuximab when administered as single agent in recurrent/ metastatic head and neck squamous cell carcinoma after the failure or intolerance of immuno-oncology or immuno-oncology combined with chemotherapy.

metastatic head and neck squamous cell cancer
head and neck cancer
metastatic squamous cell carcinoma
pd-1 inhibitor
cancer of the head
Wake Forest Baptist Comprehensive Cancer Center
 (1.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location